Get the Stockscreener App
87.98
0.40%
-0.3357
Dexcom Inc stock is traded at $87.98, with a volume of 1.10M.
It is down -0.40% in the last 24 hours and up +10.86% over the past month.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$88.32
Open:
$88.52
24h Volume:
1.10M
Relative Volume:
0.33
Market Cap:
$35.39B
Revenue:
$3.95B
Net Income/Loss:
$680.80M
P/E Ratio:
52.69
EPS:
1.67
Net Cash Flow:
$535.00M
1W Performance:
+1.31%
1M Performance:
+10.86%
6M Performance:
+26.90%
1Y Performance:
-30.52%
1-Day Range:
$87.64
$88.72
1-Week Range:
$85.00
$89.58
52-Week Range:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
87.95 | 35.39B | 3.95B | 680.80M | 535.00M | 1.67 |
|
ABT
Abbott Laboratories
|
129.00 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.70 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
393.20 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.16 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
Caprock Group LLC Purchases 3,012 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
3,816 Shares in DexCom, Inc. (NASDAQ:DXCM) Purchased by Alliance Wealth Advisors LLC UT - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Chicago Capital LLC - MarketBeat
Here’s Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM) - MSN
DexCom, Inc. (NASDAQ:DXCM) Stake Raised by Mirae Asset Global Investments Co. Ltd. - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Purchased by Jennison Associates LLC - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Stake Boosted by GDS Wealth Management - MarketBeat
DexCom (DXCM) Q4 Earnings Preview: What's in the Cards? - Yahoo Finance
Should You Buy DexCom Stock Before Feb. 13? - The Motley Fool
DexCom, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 21, 2024 to Discuss Your RightsDXCM - ACCESS Newswire
abrdn plc Sells 37,095 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Receives $99.29 Average Target Price from Brokerages - MarketBeat
DexCom (DXCM) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Factory Mutual Insurance Co. Has $37.46 Million Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Blood Glucose Monitoring Market: Current Analysis and Forecast (2022-2028) - UnivDatos Market Insights
Possible Bearish Signals With DexCom Insiders Disposing Stock - Yahoo Canada Finance
American Diversifield Holdings Corporation (ADHC) Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program - Yahoo Finance
BDF Gestion Purchases Shares of 48,703 DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) CEO Kevin R. Sayer Sells 33,359 Shares - MarketBeat
Jereme M. Sylvain Sells 2,090 Shares of DexCom, Inc. (NASDAQ:DXCM) Stock - MarketBeat
DexCom Shares Rise Following Upgrade From Redburn Atlantic -February 03, 2025 at 02:53 pm EST - Marketscreener.com
Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings) - Benzinga
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years - The Motley Fool
DexCom (NASDAQ:DXCM) Raised to Buy at Redburn Atlantic - MarketBeat
Redburn Atlantic Upgrades DexCom to Buy From Neutral, Adjusts Price Target to $115 From $85 - Marketscreener.com
Union Bancaire Privee UBP SA Acquires Shares of 3,000 DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Jacob Steven Leach Sells 2,634 Shares of DexCom, Inc. (NASDAQ:DXCM) Stock - MarketBeat
Hantz Financial Services Inc. Boosts Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Swedbank AB Grows Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Stableford Capital II LLC Raises Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Comprehensive Financial Consultants Institutional Inc. Acquires 3,049 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by SG Americas Securities LLC - Defense World
DexCom, Inc. (NASDAQ:DXCM) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Mount Yale Investment Advisors LLC Makes New $713,000 Investment in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Smith Group Asset Management LLC Acquires Shares of 42,000 DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Have Insiders Sold DexCom Shares Recently? - Simply Wall St
Mediolanum International Funds Ltd Has $11.92 Million Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
5,842 Shares in DexCom, Inc. (NASDAQ:DXCM) Acquired by Flagship Harbor Advisors LLC - MarketBeat
KBC Group NV Sells 579,068 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Fifth Third Bancorp Buys 5,553 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Dexcom Insider Sold Shares Worth $2,899,367, According to a Recent SEC Filing -January 31, 2025 at 04:09 am EST - Marketscreener.com
Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time. - Business Wire
DexCom's Crucial Q4 Report: February 13 Will Reveal Full 2024 Performance - StockTitan
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dexcom Inc Stock (DXCM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent | EVP, Strategy & Corporate Dev |
Jan 29 '25 |
Sale |
86.91 |
1,183 |
102,820 |
42,044 |
| Stern Sadie | EVP, Chief HR Officer |
Jan 29 '25 |
Sale |
86.91 |
2,093 |
181,911 |
74,261 |
| Leach Jacob Steven | EVP, Chief Operating Officer |
Jan 29 '25 |
Sale |
86.91 |
2,634 |
228,932 |
268,644 |
| SAYER KEVIN R | Chairman, CEO & President |
Jan 29 '25 |
Sale |
86.91 |
33,359 |
2,899,367 |
319,037 |
| Stern Sadie | EVP, Chief HR Officer |
Dec 16 '24 |
Sale |
76.87 |
424 |
32,593 |
70,768 |
| Sylvain Jereme M | EVP, Chief Financal Officer |
Dec 16 '24 |
Sale |
76.87 |
744 |
57,191 |
80,030 |
| Leach Jacob Steven | EVP, Chief Operating Officer |
Dec 16 '24 |
Sale |
76.87 |
744 |
57,191 |
264,171 |
| Heller Bridgette P | Director |
Dec 16 '24 |
Sale |
76.87 |
1,000 |
76,870 |
23,349 |
0.67%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):